ヘルスケアサプライチェーン管理市場 – 2030年までの世界予測

Report Overview

The global healthcare supply chain management market is projected to reach USD 5.06 billion by 2030 from USD 3.71 billion in 2024, at a CAGR of 6.4% during the forecast period.

世界のヘルスケアサプライチェーン管理市場は、2024年の37億1,000万米ドルから2030年までに50億6,000万米ドルに達すると予測されており、予測期間中のCAGRは6.4%です。

The market is expected to grow as strict regulatory and compliance demands encourage healthcare organizations to implement advanced supply chain management solutions to adhere to safety standards. Increasing healthcare expenses and the necessity for operational efficiency are also motivating the adoption of systems that enhance inventory management, minimize waste, and reduce operational costs. The shortage of skilled professionals managing complex supply chain systems makes implementation and operation more difficult. Additionally, the varying regional regulations also create challenges for internationally operating companies.

“The pharmaceutical & biotechnology segment is expected to register fastest growth during the forecast period, by product managed”

The healthcare supply chain management, by product managed segment, is segmented into pharmaceutical & biotechnology, medical devices & equipment, and others. The pharmaceutical & biotechnology segment is expected to grow the fastest during the forecast period due to the increasing demand for innovative drugs and vaccines driven by rising chronic diseases and an aging population. Advances in biotechnology, such as gene therapies and personalized medicine, add to the growth by creating complex supply chain needs. Additionally, increased concern to address global health issues combined with the imperative to quickly and compliantly distribute urgently needed medicines continues to facilitate this segment’s growth.

“On-premise segment dominated the market in the healthcare supply chain management market, by deployment model in 2023.”’

By deployment model, the healthcare supply chain management market is divided into the on-premise models and cloud based models. In 2023, on-premise models accounted to hold a significant share of the healthcare supply chain management market, by deployment model. This segment’s prominent position is due to the need to secure private and confidential data and control information workflow in the organization. The absence of incremental costs throughout the ownership of solutions compared to cloud-based deployment also drives the adoption of on-premises solutions. Additionally, internet penetration, ease of access, online documentation, the need for security requirements, and in-house hosting options are the key factors encouraging the growth of the on-premises healthcare supply chain management software market.

“Asia Pacific is expected to register the fastest market growth during the forecast period.”

The healthcare supply chain management market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. This rapid expansion can be attributed to government initiatives in the region focused on enhancing healthcare infrastructure and fostering digital transformation. This has resulted in the development of more efficient and resilient supply chains. India’s National Digital Health Mission (NDHM) aims to create a strong digital health ecosystem that boosts accessibility, quality, and efficiency in healthcare delivery while enhancing healthcare supply chain management.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation – Directors: 30%, Manager: 34%, and Others: 36%
• By Region – North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

o               Oracle (US)

o               SAP SE (Germany)

o               Infor (US)

o               IBM (US)

o               Mckesson Corporation (US)

o               Tecsys Inc. (Canada)

o               Global Healthcare Exchange, LLC. (US)

o               Cardinal Health. (US)

o               Corcentric, Inc. (US)

o               Epicor Software Corporation (US)

o               Coupa. (US)

o               Manhattan Associates (US)

o               Blue Yonder Group, Inc. (US)

o               LogiTag Systems (US)

o               Premier (US)

o               Workday, Inc. (US)

o               Arvato Systems (Germany)

o               GEP (US)

o               AmerisourceBergen Corporation. (US)

o               Procurement Partners (US)

o               Vizient  Inc. (US)

o               Jump Technologies, Inc. (US)

o               inBeam Technologies. (US)

o               ConnectSx (US)

Research Coverage:

The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing pressure on healthcare providers to improve operational efficiency and profitability, rising demand for healthcare services due to population growth and aging demographics, surging focus on cost reduction within the supply chain, demand for transparency and traceability, continuous support in the form of funding, investment, and partnerships, large scale drug counterfeiting in pharmaceutical industry), restraints (high implementation costs for advanced technologies, data security and privacy concerns), opportunities (adoption of advanced technologies like AI, IoT, and blockchain, expansion into emerging markets with growing healthcare demands, expansion of e-commerce in healthcare, enhanced focus on sustainability and eco-friendly practices in healthcare logistics), challenges (complex and varying regulatory requirements across regions, shortage of skilled professionals to manage sophisticated systems) are factors contributing the growth of the healthcare supply chain management market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Healthcare supply chain management market.
• Market Development: Comprehensive information on the lucrative emerging markets, offering, function, product managed, deployment model, end user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the healthcare supply chain management market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Healthcare supply chain management market such as Oracle (US), SAP SE (Germany), Infor (US), IBM (US), Cardinal Health (US).

Table of Contents

1               INTRODUCTION              42

1.1           STUDY OBJECTIVES       42

1.2           MARKET DEFINITION   42

1.3           STUDY SCOPE   43

1.3.1        SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD                 43

1.3.2        INCLUSIONS & EXCLUSIONS       44

1.3.3        YEARS CONSIDERED      45

1.3.4        CURRENCY CONSIDERED            46

1.4           STAKEHOLDERS               46

1.5           SUMMARY OF CHANGES               47

2               RESEARCH METHODOLOGY       49

2.1           RESEARCH DATA              49

2.1.1        SECONDARY DATA          50

2.1.1.1    Key sources for secondary data          50

2.1.1.2    Key data from secondary sources       51

2.1.2        PRIMARY DATA 51

2.1.2.1    Key primary sources             52

2.1.2.2    Objectives of primary research           52

2.1.2.3    Key industry insights           53

2.2           MARKET SIZE ESTIMATION         54

2.2.1        REVENUE SHARE ANALYSIS         54

2.2.2        BOTTOM-UP APPROACH (END-USER ADOPTION)                 55

2.2.3        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      56

2.2.4        TOP-DOWN APPROACH                58

2.3           DATA TRIANGULATION                59

2.4           MARKET SHARE ESTIMATION    60

2.5           STUDY ASSUMPTIONS  61

2.6           RESEARCH LIMITATIONS             61

2.6.1        METHODOLOGY-RELATED LIMITATIONS           61

2.6.2        SCOPE-RELATED LIMITATIONS                 61

2.7           RISK ASSESSMENT           62

3               EXECUTIVE SUMMARY  63

4               PREMIUM INSIGHTS       68

4.1           HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW          68

4.2           NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER & COUNTRY (2023)                 69

4.3           HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT            70

4.4           REGIONAL MIX: HEALTHCARE SUPPLY CHAIN MANAGEMENT (2024−2030)        71

4.5           HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DEVELOPED VS. EMERGING MARKETS  71

5               MARKET OVERVIEW       72

5.1           INTRODUCTION              72

5.2           MARKET DYNAMICS       72

5.2.1        DRIVERS               74

5.2.1.1    Increasing pressure on healthcare providers to improve operational efficiency and profitability              74

5.2.1.2    Rising demand for healthcare services due to population growth and aging demographics      74

5.2.1.3    Focus on reducing supply chain costs                75

5.2.1.4    Demand for transparency and traceability       75

5.2.1.5    Availability of funding, investments, and partnerships  76

5.2.1.6    Large-scale drug counterfeiting in pharmaceutical industry                 76

5.2.2        RESTRAINTS      77

5.2.2.1    High implementation costs for advanced technologies  77

5.2.2.2    Data security and privacy concerns   77

5.2.2.3    Supply chain disruptions due to global events or geopolitical tensions  78

5.2.3        OPPORTUNITIES              79

5.2.3.1    Increasing use of AI-powered solutions            79

5.2.3.2    Expansion into emerging markets with growing healthcare demands 79

5.2.3.3    Expansion of E-commerce in healthcare           80

5.2.3.4    Enhanced focus on sustainability and eco-friendly practices

in healthcare logistics          80

5.2.4        CHALLENGES    81

5.2.4.1    Complex and varying regulatory requirements across regions                 81

5.2.4.2    Shortage of skilled professionals to manage sophisticated systems                 82

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            82

5.4           INDUSTRY TRENDS         83

5.4.1        ERP IN HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS        83

5.4.2        CLOUD-BASED SOLUTIONS        83

5.4.3        RISING STRATEGIC INITIATIVES AND INNOVATIONS BY KEY

INDUSTRY PLAYERS       84

5.5           ECOSYSTEM ANALYSIS  85

5.6           VALUE CHAIN ANALYSIS               88

5.7           TECHNOLOGY ANALYSIS             89

5.7.1        KEY TECHNOLOGIES     89

5.7.1.1    Blockchain             90

5.7.1.2    Artificial intelligence & machine learning        90

5.7.1.3    Cloud computing  90

5.7.2        COMPLEMENTARY TECHNOLOGIES       91

5.7.2.1    Data analytics        91

5.7.2.2    Internet of Things                 91

5.7.3        ADJACENT TECHNOLOGIES       91

5.7.3.1    AR/VR   91

5.8           REGULATORY ANALYSIS               92

5.8.1        REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS             92

5.8.2        REGULATORY SCENARIO             95

5.8.3        INCREASING REGULATIONS AROUND CALIBRATION & CERTIFICATION               100

5.9           PRICING ANALYSIS          102

5.9.1        INDICATIVE PRICING OF SOLUTIONS, BY KEY PLAYER                 102

5.9.2        AVERAGE SELLING PRICE, BY REGION (QUALITATIVE)                 104

5.10         PORTER’S FIVE FORCES ANALYSIS           104

5.10.1      INTENSITY OF COMPETITIVE RIVALRY 106

5.10.2      BARGAINING POWER OF BUYERS             106

5.10.3      THREAT OF SUBSTITUTES          106

5.10.4      THREAT OF NEW ENTRANTS      106

5.10.5      BARGAINING POWER OF SUPPLIERS       106

5.11         KEY STAKEHOLDERS AND BUYING CRITERIA     107

5.11.1      KEY STAKEHOLDERS IN BUYING PROCESS           107

5.11.2      KEY BUYING CRITERIA  108

5.12         PATENT ANALYSIS          109

5.12.1      PATENT PUBLICATION TRENDS               109

5.12.2      JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT          109

5.12.3      MAJOR PATENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET               110

5.13         END-USER ANALYSIS      113

5.13.1      UNMET NEEDS 113

5.13.2      END-USER EXPECTATIONS         113

5.14         KEY CONFERENCES & EVENTS, 2024–2025              114

5.15         CASE STUDY ANALYSIS 115

5.15.1      CASE STUDY 1: TRANSFORMING SUPPLY CHAIN AT DAYTON

CHILDREN’S HOSPITAL 115

5.15.2      CASE STUDY 2: OLYMPUS CORPORATION’S PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT                 116

5.15.3      CASE STUDY 3: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS                 116

5.16         INVESTMENT AND FUNDING SCENARIO               117

5.17         BUSINESS MODELS         117

5.18         TRADE ANALYSIS             118

5.18.1      IMPORT SCENARIO FOR HS CODE 847190              118

5.18.2      EXPORT SCENARIO FOR HS CODE 847190              119

5.19         IMPACT OF AI/GEN AI ON HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET               120

5.19.1      KEY USE CASES 121

5.19.2      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         122

5.19.2.1  Case Study 1: Enhancing supply chain with AI solutions at NHS Blood and Transplant          122

5.19.2.2  Case Study 2: Leveraging AI for proactive infection prevention in hospitals 122

5.19.3      IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              123

5.19.3.1  Healthcare IT market           124

5.19.3.2  Supply chain management market     124

5.19.3.3  Healthcare analytics market                124

5.19.3.4  Cloud ERP market                124

5.19.4      USER READINESS AND IMPACT ASSESSMENT     125

5.19.4.1  User readiness       125

5.19.4.1.1                User A: Manufacturers        125

5.19.4.1.2                User B: Distributors             125

5.19.4.1.3                User C: Providers 125

5.19.4.2  Impact assessment                125

5.19.4.2.1                User A: Manufacturers        125

5.19.4.2.1.1            Implementation    125

5.19.4.2.1.2            Impact    126

5.19.4.2.2                User B: Distributors             126

5.19.4.2.2.1            Implementation    126

5.19.4.2.2.2            Impact    126

5.19.4.2.3                User C: Providers 126

5.19.4.2.3.1            Implementation    126

5.19.4.2.3.2            Impact    127

6               HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING    128

6.1           INTRODUCTION              129

6.2           SOFTWARE         129

6.2.1        ENTIRE SUPPLY CHAIN SUITES 131

6.2.1.1    Need for end-to-end visibility and real-time insights to drive market growth       131

6.2.2        SUPPLY CHAIN PLANNING SOFTWARE  132

6.2.2.1    Need for effective and efficient supply chain planning to fuel market growth       132

6.2.3        SUPPLIER RELATIONSHIP MANAGEMENT (SRM) SOFTWARE         134

6.2.3.1    Benefit of enhanced supplier collaboration to drive segmental growth    134

6.2.4        SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT SOFTWARE         135

6.2.4.1    Need for effective supply chain business network to boost market                 135

6.2.5        SUPPLY CHAIN COST-TO-SERVE ANALYSIS SOFTWARE                 136

6.2.5.1    Pressing need to cut costs and improve operational efficiency to drive growth          136

6.2.6        SUPPLY CHAIN ANALYTICS SOFTWARE 138

6.2.6.1    Advancements in artificial intelligence for data analytics to drive market growth       138

6.2.7        SUPPLY CHAIN VISIBILITY SOFTWARE  139

6.2.7.1    Greater visibility and maintenance across supply chain to drive market growth       139

6.3           HARDWARE        140

6.3.1        BARCODES & BARCODE SCANNERS         141

6.3.1.1    Need for better tracking and traceability of medical devices to drive market growth             141

6.3.2        SYSTEMS              142

6.3.2.1    Advantages of smart cabinets in effective inventory management to drive segment   142

6.3.3        RFID TAGS & READERS  144

6.3.3.1    Crucial role of RFIDs in asset tracking and inventory management to drive market growth 144

6.3.4        OTHER HARDWARE COMPONENTS         145

6.4           SERVICES             146

6.4.1        MANAGED SERVICES      147

6.4.1.1    Benefit of being able to focus on core business activities to drive demand for managed services             147

6.4.2        PROFESSIONAL SERVICES            149

6.4.2.1    Perks of running supply chains with expert advice to drive demand for professional services       149

7               HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION   151

7.1           INTRODUCTION              152

7.2           PURCHASING MANAGEMENT    152

7.2.1        SUPPLY MANAGEMENT                 154

7.2.1.1    Growing investments in supplier relationship management to boost market          154

7.2.2        PROCUREMENT                155

7.2.2.1    Need for optimized data storage and management to accelerate growth    155

7.2.3        CAPITAL PURCHASING 157

7.2.3.1    Increasing use by equipment providers, suppliers, and facilitators to foster growth    157

7.2.4        STRATEGIC SOURCING 158

7.2.4.1    Rising inclination toward data-driven decision making to aid growth    158

7.2.5        TRANSPORTATION MANAGEMENT         159

7.2.5.1    Increasing demand for streamlined logistics operations to sustain growth    159

7.3           INVENTORY MANAGEMENT       161

7.3.1        ORDER MANAGEMENT 163

7.3.1.1    Need for automated order fulfillment process to promote growth                 163

7.3.2        WAREHOUSE MANAGEMENT     164

7.3.2.1    Rise in advancements in warehouse design and labor management to drive market              164

7.3.3        CONSIGNMENT MANAGEMENT                166

7.3.3.1    Growing demand for reduced supply chain expenses to boost market    166

7.3.4        IMPLANT MANAGEMENT             167

7.3.4.1    Need to track and trace implants to promote growth     167

7.3.5        TISSUE MANAGEMENT 168

7.3.5.1    Expanding applications of human tissue implants to spur growth                 168

8               HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED              170

8.1           INTRODUCTION              171

8.2           PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS                 171

8.2.1        SMALL-MOLECULE DRUGS         173

8.2.1.1    Need for efficient logistics to ensure timely delivery of small-molecule drugs to boost adoption of supply chain solutions          173

8.2.2        VACCINES           175

8.2.2.1    Need for robust infrastructure and advanced tracking systems to drive market growth             175

8.2.3        MONOCLONAL ANTIBODIES, BIOSIMILARS, AND MRNAS 177

8.2.3.1    New supply chain requirements fueled by ongoing advancements in biotechnology to support market growth     177

8.2.4        CELL & GENE THERAPY (CGT) PRODUCTS           178

8.2.4.1    Driving innovation in cell & gene therapy through strategic supply chain solutions to boost market             178

8.2.5        OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS         180

8.3           MEDICAL DEVICES & EQUIPMENT           181

8.3.1        SURGICAL INSTRUMENTS            182

8.3.1.1    Advancing surgical care through enhanced management of surgical instruments and logistics to contribute to growth             182

8.3.2        DIAGNOSTIC & THERAPEUTIC EQUIPMENT       184

8.3.2.1    Need for robust supply chain to handle complexities in diagnostic & therapeutic equipment to boost growth        184

8.3.3        MONITORING DEVICES 185

8.3.3.1    Growing need for effective supply chain management of monitoring devices to fuel growth     185

8.3.4        IMPLANTS & PROSTHETICS        187

8.3.4.1    Requirement of specialized manufacturing, sterilization, and distribution processes to propel market            187

8.3.5        OTHER MEDICAL DEVICES & EQUIPMENT           188

8.4           OTHER PRODUCTS MANAGED  189

9               HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL            190

9.1           INTRODUCTION              191

9.2           ON-PREMISE MODELS   191

9.2.1        GROWING REQUIREMENT FOR DATA PRIVACY AND SECURITY TO DRIVE MARKET   191

9.3           CLOUD-BASED MODELS               193

9.3.1        NEED FOR COST-EFFECTIVE DATA SHARING TO STIMULATE GROWTH   193

10            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER     195

10.1         INTRODUCTION              196

10.1.1      MANUFACTURERS           196

10.1.1.1  Medical & surgical device manufacturers         198

10.1.1.1.1                Growing demand for advanced medical technologies to drive market          198

10.1.1.2  Pharmaceutical & biotechnology companies    199

10.1.1.2.1                Need to adhere to stringent regulatory requirements to augment growth    199

10.1.2      DISTRIBUTORS 201

10.1.2.1  Primary pharmaceutical distributors 202

10.1.2.1.1                Increasing focus on risk mitigation to speed up growth                 202

10.1.2.2  Wholesalers           203

10.1.2.2.1                Growing complexity of global supply chain to fuel market    203

10.1.2.3  Group purchasing organizations        205

10.1.2.3.1                Rising need for simplified procurement process

to favor growth      205

10.1.3      HEALTHCARE PROVIDERS           206

10.1.3.1  Hospitals & clinics                208

10.1.3.1.1                Rising demand for improved patient outcomes

to facilitate growth                208

10.1.3.2  Pharmacies            210

10.1.3.2.1                Increasing reliance on barcode scanning and integrated software systems to aid growth           210

10.1.3.3  Ambulatory surgical centers                211

10.1.3.3.1                Need for effective inventory management to encourage growth    211

10.1.3.4  Other healthcare providers 212

11            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION         214

11.1         INTRODUCTION              215

11.2         NORTH AMERICA             215

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 217

11.2.2      US           224

11.2.2.1  Growing collaborations among market players to drive market                 224

11.2.3      CANADA               232

11.2.3.1  Increasing adoption of digital technologies to promote growth                 232

11.3         EUROPE               240

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      241

11.3.2      GERMANY           248

11.3.2.1  Booming medical device market to propel market          248

11.3.3      UK          256

11.3.3.1  Growing health service initiatives by government bodies

to drive market      256

11.3.4      FRANCE                264

11.3.4.1  Evolving digital health landscape to augment growth     264

11.3.5      SPAIN    272

11.3.5.1  Rise in chronic diseases to encourage growth  272

11.3.6      ITALY    280

11.3.6.1  Increasing initiatives in pharmaceutical and healthcare sectors

to aid growth         280

11.3.7      NORDIC COUNTRIES     287

11.3.7.1  Rising healthcare expenditure to facilitate growth          287

11.3.8      REST OF EUROPE             295

11.4         ASIA PACIFIC     303

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 303

11.4.2      JAPAN   312

11.4.2.1  Dominant aging population to accelerate growth            312

11.4.3      CHINA  320

11.4.3.1  Expanding healthcare infrastructure to fuel market        320

11.4.4      INDIA    328

11.4.4.1  Increasing healthcare access to spur growth    328

11.4.5      REST OF ASIA PACIFIC   336

11.5         LATIN AMERICA                344

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 344

11.5.2      BRAZIL 351

11.5.2.1  Growing modernization efforts to propel market            351

11.5.3      MEXICO                360

11.5.3.1  Growing foreign investment to boost market  360

11.5.4      REST OF LATIN AMERICA             367

11.6         MIDDLE EAST & AFRICA                374

11.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 375

11.6.2      GCC COUNTRIES              382

11.6.2.1  Rising healthcare investments to facilitate growth          382

11.6.3      REST OF MIDDLE EAST & AFRICA             390

12            COMPETITIVE LANDSCAPE         398

12.1         INTRODUCTION              398

12.2         KEY PLAYER STRATEGY/RIGHT TO WIN                398

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET                 398

12.3         REVENUE ANALYSIS, 2019–2023  402

12.4         MARKET SHARE ANALYSIS, 2023                 403

12.4.1      RANKING OF KEY MARKET PLAYERS       406

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 406

12.5.1      STARS   406

12.5.2      EMERGING LEADERS     406

12.5.3      PERVASIVE PLAYERS      406

12.5.4      PARTICIPANTS 407

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         408

12.5.5.1  Company footprint               408

12.5.5.2  Region footprint   409

12.5.5.3  Offering footprint 410

12.5.5.4  Function footprint                411

12.5.5.5  End-user footprint                412

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        413

12.6.1      PROGRESSIVE COMPANIES         413

12.6.2      RESPONSIVE COMPANIES            413

12.6.3      DYNAMIC COMPANIES  413

12.6.4      STARTING BLOCKS         413

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 415

12.7         COMPANY VALUATION & FINANCIAL METRICS 416

12.7.1      FINANCIAL METRICS      416

12.7.2      COMPANY VALUATION 417

12.8         BRAND/PRODUCT COMPARISON             418

12.9         COMPETITIVE SCENARIO             419

12.9.1      SOLUTION/SERVICE LAUNCHES & ENHANCEMENTS                 419

12.9.2      DEALS  420

12.9.3      EXPANSIONS     421

13            COMPANY PROFILES      423

13.1         KEY PLAYERS     423

13.1.1      SAP SE  423

13.1.1.1  Business overview 423

13.1.1.2  Products/Services/Solutions offered 424

13.1.1.3  Recent developments           426

13.1.1.3.1                Solution enhancements       426

13.1.1.4  MnM view              426

13.1.1.4.1                Right to win           426

13.1.1.4.2                Strategic choices   427

13.1.1.4.3                Weaknesses & competitive threats     427

13.1.2      ORACLE                428

13.1.2.1  Business overview 428

13.1.2.2  Products/Services/Solutions offered 429

13.1.2.3  Recent developments           430

13.1.2.3.1                Solution enhancements       430

13.1.2.3.2                Deals      431

13.1.2.3.3                Expansions             431

13.1.2.4  MnM view              431

13.1.2.4.1                Right to win           431

13.1.2.4.2                Strategic choices   432

13.1.2.4.3                Weaknesses & competitive threats     432

13.1.3      IBM        433

13.1.3.1  Business overview 433

13.1.3.2  Products/Services/Solutions offered 434

13.1.3.3  Recent developments           435

13.1.3.3.1                Deals      435

13.1.3.4  MnM view              436

13.1.3.4.1                Right to win           436

13.1.3.4.2                Strategic choices   437

13.1.3.4.3                Weaknesses & competitive threats     437

13.1.4      CARDINAL HEALTH        438

13.1.4.1  Business overview 438

13.1.4.2  Products/Services/Solutions offered 439

13.1.4.3  Recent developments           442

13.1.4.3.1                Deals      442

13.1.4.3.2                Expansions             444

13.1.4.4  MnM view              445

13.1.4.4.1                Right to win           445

13.1.4.4.2                Strategic choices   445

13.1.4.4.3                Weaknesses & competitive threats     445

13.1.5      INFOR (KOCH INDUSTRIES)       446

13.1.5.1  Business overview 446

13.1.5.2  Products/Services/Solutions offered 446

13.1.5.3  Recent developments           448

13.1.5.3.1                Deals      448

13.1.5.4  MnM view              449

13.1.5.4.1                Right to win           449

13.1.5.4.2                Strategic choices   449

13.1.5.4.3                Weaknesses & competitive threats     449

13.1.6      MANHATTAN ASSOCIATES          450

13.1.6.1  Business overview 450

13.1.6.2  Products/Services/Solutions offered 451

13.1.7      TECSYS INC.       454

13.1.7.1  Business overview 454

13.1.7.2  Products/Services/Solutions offered 455

13.1.7.3  Recent developments           457

13.1.7.3.1                Solution enhancements       457

13.1.7.3.2                Deals      457

13.1.8      GLOBAL HEALTHCARE EXCHANGE, LLC                459

13.1.8.1  Business overview 459

13.1.8.2  Products/Services/Solutions offered 459

13.1.8.3  Recent developments           462

13.1.8.3.1                Service/Solution launches & enhancements    462

13.1.8.3.2                Deals      463

13.1.8.3.3                Expansions             464

13.1.9      EPICOR SOFTWARE CORPORATION        465

13.1.9.1  Business overview 465

13.1.9.2  Products/Services/Solutions offered 465

13.1.9.3  Recent developments           467

13.1.9.3.1                Software launches 467

13.1.9.3.2                Deals      468

13.1.10   CORCENTRIC, INC.          470

13.1.10.1                 Business overview 470

13.1.10.2                 Products/Services/Solutions offered 470

13.1.10.3                 Recent developments           471

13.1.10.3.1             Deals      471

13.1.11   MCKESSON CORPORATION         473

13.1.11.1                 Business overview 473

13.1.11.2                 Products/Services/Solutions offered 474

13.1.11.3                 Recent developments           476

13.1.11.3.1             Solution launches 476

13.1.11.3.2             Deals      476

13.1.12   COUPA 477

13.1.12.1                 Business overview 477

13.1.12.2                 Products/Services/Solutions offered 477

13.1.12.3                 Recent developments           479

13.1.12.3.1             Solution launches 479

13.1.12.3.2             Deals      480

13.1.12.3.3             Expansions             480

13.1.13   BLUE YONDER GROUP, INC. (PANASONIC CORPORATION)               481

13.1.13.1                 Business overview 481

13.1.13.2                 Products/Services/Solutions offered 482

13.1.13.3                 Recent developments           484

13.1.13.3.1             Product enhancements        484

13.1.13.3.2             Deals      485

13.1.14   LOGITAG SYSTEMS         486

13.1.14.1                 Business overview 486

13.1.14.2                 Products/Services/Solutions offered 486

13.1.15   PREMIER              488

13.1.15.1                 Business overview 488

13.1.15.2                 Products/Services/Solutions offered 489

13.1.15.3                 Recent developments           490

13.1.15.3.1             Solution launches 490

13.1.15.3.2             Deals      491

13.1.16   WORKDAY, INC.                494

13.1.16.1                 Business overview 494

13.1.16.2                 Products/Services/Solutions offered 495

13.1.16.3                 Recent developments           496

13.1.16.3.1             Solution launches 496

13.1.16.3.2             Deals      497

13.1.17   ARVATO SE (BERTELSMANN SE & CO. KGAA)      498

13.1.17.1                 Business overview 498

13.1.17.2                 Products/Services/Solutions offered 499

13.1.17.3                 Recent developments           501

13.1.17.3.1             Deals      501

13.1.18   CENCORA, INC. 502

13.1.18.1                 Business overview 502

13.1.18.2                 Products/Services/Solutions offered 503

13.1.18.3                 Recent developments           504

13.1.18.3.1             Service launches   504

13.1.18.3.2             Deals      504

13.1.18.3.3             Expansions             505

13.1.19   GEP        507

13.1.19.1                 Business overview 507

13.1.19.2                 Products/Services/Solutions offered 508

13.1.19.3                 Recent developments           510

13.1.19.3.1             Solution launches 510

13.1.19.3.2             Deals      510

13.1.19.3.3             Expansions             511

13.2         OTHER PLAYERS              512

13.2.1      JUMP TECHNOLOGIES, INC.        512

13.2.2      MEDSPHERE SYSTEMS CORPORATION  513

13.2.3      PROMEDEO        514

13.2.4      PROCUREMENT PARTNERS         515

13.2.5      VIZIENT INC.     516

13.2.6      INBEAM TECHNOLOGIES             517

13.2.7      CONNECTSX      518

14            APPENDIX           519

14.1         DISCUSSION GUIDE        519

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                524

14.3         CUSTOMIZATION OPTIONS        526

14.4         RELATED REPORTS         527

14.5         AUTHOR DETAILS           528

LIST OF TABLES

TABLE 1                HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: INCLUSIONS & EXCLUSIONS   44

TABLE 2                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                46

TABLE 3                HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: STUDY ASSUMPTIONS               61

TABLE 4                HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: RISK ASSESSMENT       62

TABLE 5                HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: IMPACT ANALYSIS       73

TABLE 6                HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ROLE IN ECOSYSTEM 87

TABLE 7                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 92

TABLE 8                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           93

TABLE 9                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  93

TABLE 10              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 11              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  95

TABLE 12              NORTH AMERICA: RELEVANT REGULATIONS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT          95

TABLE 13              EUROPE: RELEVANT REGULATIONS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT    96

TABLE 14              ASIA PACIFIC: RELEVANT REGULATIONS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT    97

TABLE 15              MIDDLE EAST & AFRICA: RELEVANT REGULATIONS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT 99

TABLE 16              LATIN AMERICA: RELEVANT REGULATIONS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT          100

TABLE 17              INDICATIVE PRICING OF HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS, BY KEY PLAYER       103

TABLE 18              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS       105

TABLE 19              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE

END USERS (%) 107

TABLE 20              KEY BUYING CRITERIA FOR TOP THREE END USERS   108

TABLE 21              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT                 110

TABLE 22              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: LIST OF PATENTS/

PATENT APPLICATIONS               111

TABLE 23              UNMET NEEDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET               113

TABLE 24              END-USER EXPECTATIONS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET               114

TABLE 25              LIST OF CONFERENCES AND EVENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT    114

TABLE 26              IMPORT DATA FOR HS CODE 847190, BY COUNTRY,

2019–2023 (USD THOUSAND)      118

TABLE 27              EXPORT DATA FOR HS CODE 847190, BY COUNTRY,

2019–2023 (USD THOUSAND)      119

TABLE 28              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2022–2030 (USD MILLION)            129

TABLE 29              HEALTHCARE SUPPLY CHAIN MANAGEMENT SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            130

TABLE 30              HEALTHCARE SUPPLY CHAIN MANAGEMENT SOFTWARE MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               131

TABLE 31              ENTIRE SUPPLY CHAIN SUITES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)     132

TABLE 32              SUPPLY CHAIN PLANNING SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            133

TABLE 33              SUPPLIER RELATIONSHIP MANAGEMENT (SRM) SOFTWARE MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               135

TABLE 34              SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT SOFTWARE MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               136

TABLE 35              SUPPLY CHAIN COST-TO-SERVE ANALYSIS SOFTWARE MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               137

TABLE 36             SUPPLY CHAIN ANALYTICS SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            138

TABLE 37              SUPPLY CHAIN VISIBILITY SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            139

TABLE 38              HEALTHCARE SUPPLY CHAIN MANAGEMENT HARDWARE MARKET,

BY TYPE, 2022–2030 (USD MILLION)         140

TABLE 39              HEALTHCARE SUPPLY CHAIN MANAGEMENT HARDWARE MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               141

TABLE 40              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR BARCODES & BARCODE SCANNERS, BY COUNTRY, 2022–2030 (USD MILLION)            142

TABLE 41              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SYSTEMS, BY COUNTRY, 2022–2030 (USD MILLION)                 143

TABLE 42              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR RFID TAGS & READERS, BY COUNTRY, 2022–2030 (USD MILLION) 144

TABLE 43              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HARDWARE COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION)            145

TABLE 44              HEALTHCARE SUPPLY CHAIN MANAGEMENT SERVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         146

TABLE 45              HEALTHCARE SUPPLY CHAIN MANAGEMENT SERVICES MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               147

TABLE 46              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANAGED SERVICES, BY COUNTRY, 2022–2030 (USD MILLION) 149

TABLE 47              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2022–2030 (USD MILLION)       150

TABLE 48              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            152

TABLE 49              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 153

TABLE 50              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)       153

TABLE 51              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION) 155

TABLE 52              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROCUREMENT,

BY COUNTRY, 2022–2030 (USD MILLION)               156

TABLE 53              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CAPITAL PURCHASING, BY COUNTRY, 2022–2030 (USD MILLION) 157

TABLE 54              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR STRATEGIC SOURCING, BY COUNTRY, 2022–2030 (USD MILLION) 159

TABLE 55              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TRANSPORTATION MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)            161

TABLE 56              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 162

TABLE 57              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)       162

TABLE 58              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ORDER MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION) 164

TABLE 59              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WAREHOUSE MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)       165

TABLE 60              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CONSIGNMENT MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)            166

TABLE 61              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANT MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION)       168

TABLE 62              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TISSUE MANAGEMENT, BY COUNTRY, 2022–2030 (USD MILLION) 169

TABLE 63              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION)                 171

TABLE 64              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)                172

TABLE 65              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2022–2030 (USD MILLION)     173

TABLE 66              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SMALL-MOLECULE DRUGS, BY COUNTRY, 2022–2030 (USD MILLION)       175

TABLE 67              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR VACCINES,

BY COUNTRY, 2022–2030 (USD MILLION)               176

TABLE 68              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONOCLONAL ANTIBODIES, BIOSIMILARS, AND MRNAS, BY COUNTRY,

2022–2030 (USD MILLION)            178

TABLE 69              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CELL & GENE THERAPY (CGT) PRODUCTS, BY COUNTRY, 2022–2030 (USD MILLION)     179

TABLE 70              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY COUNTRY,

2022–2030 (USD MILLION)            180

TABLE 71              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)       181

TABLE 72              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2022–2030 (USD MILLION)            182

TABLE 73              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SURGICAL INSTRUMENTS, BY COUNTRY, 2022–2030 (USD MILLION)       183

TABLE 74              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DIAGNOSTIC & THERAPEUTIC EQUIPMENT, BY COUNTRY, 2022–2030 (USD MILLION)     185

TABLE 75              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONITORING DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 186

TABLE 76              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANTS & PROSTHETICS, BY COUNTRY, 2022–2030 (USD MILLION)       187

TABLE 77              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2022–2030 (USD MILLION)     188

TABLE 78              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER PRODUCTS MANAGED, BY COUNTRY, 2022–2030 (USD MILLION)            189

TABLE 79              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 191

TABLE 80              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ON-PREMISE MODELS, BY COUNTRY, 2022–2030 (USD MILLION) 192

TABLE 81              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2022–2030 (USD MILLION) 194

TABLE 82              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2022–2030 (USD MILLION)            196

TABLE 83              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS,

BY TYPE, 2022–2030 (USD MILLION)         197

TABLE 84              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS,

BY COUNTRY, 2022–2030 (USD MILLION)               197

TABLE 85              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL & SURGICAL DEVICE MANUFACTURERS, BY COUNTRY, 2022–2030 (USD MILLION)               199

TABLE 86              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2030 (USD MILLION)   200

TABLE 87              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS,

BY TYPE, 2022–2030 (USD MILLION)         201

TABLE 88              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS,

BY COUNTRY, 2022–2030 (USD MILLION)               202

TABLE 89              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PRIMARY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2022–2030 (USD MILLION)     203

TABLE 90              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WHOLESALERS,

BY COUNTRY, 2022–2030 (USD MILLION)               204

TABLE 91              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2022–2030 (USD MILLION)     206

TABLE 92              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 207

TABLE 93              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2022–2030 (USD MILLION)       208

TABLE 94              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 209

TABLE 95              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACIES,

BY COUNTRY, 2022–2030 (USD MILLION)               210

TABLE 96              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022–2030 (USD MILLION)            212

TABLE 97              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2022–2030 (USD MILLION)            213

TABLE 98              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION,

2022–2030 (USD MILLION)            215

TABLE 99              NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               217

TABLE 100            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               218

TABLE 101            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 218

TABLE 102            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 219

TABLE 103            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION) 219

TABLE 104            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             219

TABLE 105            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                220

TABLE 106            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                220

TABLE 107            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        221

TABLE 108            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            221

TABLE 109            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         222

TABLE 110            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     222

TABLE 111            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               223

TABLE 112            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)                 223

TABLE 113            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       224

TABLE 114            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR HEALTHCARE PROVIDERS, 2022–2030 (USD MILLION)                 224

TABLE 115            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2022–2030 (USD MILLION)            225

TABLE 116            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         226

TABLE 117            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         226

TABLE 118            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         227

TABLE 119            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            227

TABLE 120            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                228

TABLE 121            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                228

TABLE 122            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT

MANAGED, 2022–2030 (USD MILLION)    229

TABLE 123            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            229

TABLE 124            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         230

TABLE 125            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 230

TABLE 126            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2022–2030 (USD MILLION)            231

TABLE 127            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       231

TABLE 128            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS,

BY TYPE, 2022–2030 (USD MILLION)         232

TABLE 129            US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                232

TABLE 130            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            233

TABLE 131            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         234

TABLE 132            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 234

TABLE 133            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         235

TABLE 134            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            235

TABLE 135            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                236

TABLE 136            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                236

TABLE 137            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 237

TABLE 138            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            237

TABLE 139            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         238

TABLE 140            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 238

TABLE 141            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            239

TABLE 142            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       239

TABLE 143            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       240

TABLE 144            CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                240

TABLE 145            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)            241

TABLE 146            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            242

TABLE 147            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         242

TABLE 148            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 243

TABLE 149            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE,

BY TYPE, 2022–2030 (USD MILLION)         243

TABLE 150            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            243

TABLE 151            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                244

TABLE 152            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                244

TABLE 153            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 245

TABLE 154            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            245

TABLE 155            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         246

TABLE 156            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 246

TABLE 157            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            247

TABLE 158            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       247

TABLE 159            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       248

TABLE 160            EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                248

TABLE 161            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            249

TABLE 162            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 250

TABLE 163            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 250

TABLE 164            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION) 251

TABLE 165            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             251

TABLE 166            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                252

TABLE 167            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                252

TABLE 168            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        253

TABLE 169            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            253

TABLE 170            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         254

TABLE 171            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     254

TABLE 172            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               255

TABLE 173            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       255

TABLE 174            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       256

TABLE 175            GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                256

TABLE 176            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2022–2030 (USD MILLION)            257

TABLE 177            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         258

TABLE 178            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         258

TABLE 179            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         259

TABLE 180            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            259

TABLE 181            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                260

TABLE 182            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                260

TABLE 183            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 261

TABLE 184            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            261

TABLE 185            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         262

TABLE 186            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 262

TABLE 187            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2022–2030 (USD MILLION)            263

TABLE 188            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       263

TABLE 189            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS,

BY TYPE, 2022–2030 (USD MILLION)         264

TABLE 190            UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                264

TABLE 191            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            265

TABLE 192            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         266

TABLE 193            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 266

TABLE 194            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE,

BY TYPE 2022–2030 (USD MILLION)          267

TABLE 195            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            267

TABLE 196            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                268

TABLE 197            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                268

TABLE 198            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 269

TABLE 199            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2022–2030 (USD MILLION) 269

TABLE 200            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         270

TABLE 201            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 270

TABLE 202            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            271

TABLE 203            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       271

TABLE 204            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       272

TABLE 205            FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                272

TABLE 206            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            273

TABLE 207            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         273

TABLE 208            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         274

TABLE 209            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         274

TABLE 210            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            274

TABLE 211            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                275

TABLE 212            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                275

TABLE 213            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 276

TABLE 214            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            276

TABLE 215            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         277

TABLE 216            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 277

TABLE 217            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            278

TABLE 218            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       278

TABLE 219            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       279

TABLE 220            SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                279

TABLE 221            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2022–2030 (USD MILLION)            280

TABLE 222            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         281

TABLE 223            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         281

TABLE 224            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE,

BY TYPE, 2022–2030 (USD MILLION)         282

TABLE 225            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            282

TABLE 226            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                283

TABLE 227            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                283

TABLE 228            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 284

TABLE 229            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            284

TABLE 230            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         285

TABLE 231            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 285

TABLE 232            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2022–2030 (USD MILLION)            286

TABLE 233            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       286

TABLE 234            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       287

TABLE 235            ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                287

TABLE 236            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               288

TABLE 237            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION)       289

TABLE 238            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION)            289

TABLE 239            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION)       290

TABLE 240            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             290

TABLE 241            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        291

TABLE 242            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        291

TABLE 243            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        292

TABLE 244            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            292

TABLE 245            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)             293

TABLE 246            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     293

TABLE 247            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               294

TABLE 248            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)                294

TABLE 249            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)            295

TABLE 250            NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)         295

TABLE 251            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               296

TABLE 252            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 296

TABLE 253            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 297

TABLE 254            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION) 297

TABLE 255            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             297

TABLE 256            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                298

TABLE 257            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                298

TABLE 258            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        299

TABLE 259            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            299

TABLE 260            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         300

TABLE 261            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     300

TABLE 262            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               301

TABLE 263            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       301

TABLE 264            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       302

TABLE 265            REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE 2022–2030 (USD MILLION) 302

TABLE 266            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)            305

TABLE 267            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            305

TABLE 268            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 306

TABLE 269            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 306

TABLE 270            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY TYPE, 2022–2030 (USD MILLION)            307

TABLE 271            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            307

TABLE 272            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                308

TABLE 273            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                308

TABLE 274            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        309

TABLE 275            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            309

TABLE 276            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         310

TABLE 277            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     310

TABLE 278            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               311

TABLE 279            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       311

TABLE 280            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       312

TABLE 281            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                312

TABLE 282            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            313

TABLE 283            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         314

TABLE 284            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         314

TABLE 285            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         315

TABLE 286            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            315

TABLE 287            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                316

TABLE 288            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                316

TABLE 289            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 317

TABLE 290            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            317

TABLE 291            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         318

TABLE 292            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     318

TABLE 293            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               319

TABLE 294            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       319

TABLE 295            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       320

TABLE 296            JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                320

TABLE 297            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            321

TABLE 298            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         322

TABLE 299            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         322

TABLE 300            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         323

TABLE 301            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            323

TABLE 302            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                324

TABLE 303            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                324

TABLE 304            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 325

TABLE 305            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            325

TABLE 306            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         326

TABLE 307            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 326

TABLE 308            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            327

TABLE 309            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       327

TABLE 310            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       328

TABLE 311            CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                328

TABLE 312            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2022–2030 (USD MILLION)            329

TABLE 313            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         330

TABLE 314            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         330

TABLE 315            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         331

TABLE 316            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            331

TABLE 317            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                332

TABLE 318            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                332

TABLE 319            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 333

TABLE 320            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            333

TABLE 321            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         334

TABLE 322            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 334

TABLE 323            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2022–2030 (USD MILLION)            335

TABLE 324            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       335

TABLE 325            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       336

TABLE 326            INDIA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                336

TABLE 327            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               337

TABLE 328            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION)       337

TABLE 329            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION)            338

TABLE 330            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE 2022–2030 (USD MILLION)       338

TABLE 331            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             338

TABLE 332            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        339

TABLE 333            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        339

TABLE 334            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        340

TABLE 335            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            340

TABLE 336            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)             341

TABLE 337            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     341

TABLE 338            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               342

TABLE 339            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)                 342

TABLE 340            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)            343

TABLE 341            REST OF ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)         343

TABLE 342            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               344

TABLE 343            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               345

TABLE 344            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 345

TABLE 345            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 346

TABLE 346            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION) 346

TABLE 347            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             346

TABLE 348            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            347

TABLE 349            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                347

TABLE 350            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        348

TABLE 351            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2022–2030 (USD MILLION) 348

TABLE 352            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         349

TABLE 353            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     349

TABLE 354            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               350

TABLE 355            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       350

TABLE 356            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       351

TABLE 357            LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                351

TABLE 358            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            352

TABLE 359            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         353

TABLE 360            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE,

BY TYPE, 2022–2030 (USD MILLION)         353

TABLE 361            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES,

BY TYPE, 2022–2030 (USD MILLION)         354

TABLE 362            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            354

TABLE 363            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                355

TABLE 364            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                355

TABLE 365            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 356

TABLE 366            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            356

TABLE 367            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         357

TABLE 368            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 357

TABLE 369            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            358

TABLE 370            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       358

TABLE 371            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       359

TABLE 372            BRAZIL: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                359

TABLE 373            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)            360

TABLE 374            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         361

TABLE 375            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 361

TABLE 376            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE,

BY TYPE, 2022–2030 (USD MILLION)         362

TABLE 377            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            362

TABLE 378            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                363

TABLE 379            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                363

TABLE 380            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION) 364

TABLE 381            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            364

TABLE 382            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         365

TABLE 383            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 365

TABLE 384            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)            366

TABLE 385            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       366

TABLE 386            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       367

TABLE 387            MEXICO: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                367

TABLE 388            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               368

TABLE 389            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION)                368

TABLE 390            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE 2022–2030 (USD MILLION) 369

TABLE 391            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION)                369

TABLE 392            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             369

TABLE 393            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        370

TABLE 394            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        370

TABLE 395            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        371

TABLE 396            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            371

TABLE 397            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         372

TABLE 398            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     372

TABLE 399            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               373

TABLE 400            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)         373

TABLE 401            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)         374

TABLE 402            REST OF LATIN AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)               374

TABLE 403            MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY REGION,

2022–2030 (USD MILLION)            375

TABLE 404            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               376

TABLE 405            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION)      376

TABLE 406            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION)     377

TABLE 407            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION)       377

TABLE 408            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             377

TABLE 409            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        378

TABLE 410            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        378

TABLE 411            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        379

TABLE 412            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            379

TABLE 413            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)            380

TABLE 414            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     380

TABLE 415            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               381

TABLE 416            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)                 381

TABLE 417            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)                 382

TABLE 418            MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            382

TABLE 419            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY OFFERING, 2022–2030 (USD MILLION)               383

TABLE 420            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 384

TABLE 421            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION) 384

TABLE 422            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION) 385

TABLE 423            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY FUNCTION, 2022–2030 (USD MILLION)             385

TABLE 424            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            386

TABLE 425            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET

FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            386

TABLE 426            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY PRODUCT MANAGED, 2022–2030 (USD MILLION)        387

TABLE 427            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            387

TABLE 428            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2022–2030 (USD MILLION)         388

TABLE 429            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     388

TABLE 430            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,

BY END USER, 2022–2030 (USD MILLION)               389

TABLE 431            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)       389

TABLE 432            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)       390

TABLE 433            GCC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                390

TABLE 434            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2022–2030 (USD MILLION)       391

TABLE 435            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION)                391

TABLE 436            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2022–2030 (USD MILLION)                392

TABLE 437            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2022–2030 (USD MILLION)                392

TABLE 438            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2022–2030 (USD MILLION)       392

TABLE 439            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        393

TABLE 440            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)        393

TABLE 441            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2022–2030 (USD MILLION)    394

TABLE 442            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY TYPE,

2022–2030 (USD MILLION)            394

TABLE 443            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE,

2022–2030 (USD MILLION)            395

TABLE 444            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)           395

TABLE 445            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2022–2030 (USD MILLION)       396

TABLE 446            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2022–2030 (USD MILLION)         396

TABLE 447            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2022–2030 (USD MILLION)         397

TABLE 448            REST OF MIDDLE EAST & AFRICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)               397

TABLE 449            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, JANUARY 2021–DECEMBER 2024             398

TABLE 450            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SHARE, 2023     404

TABLE 451            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: REGION FOOTPRINT 409

TABLE 452            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: OFFERING FOOTPRINT             410

TABLE 453            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: FUNCTION FOOTPRINT            411

TABLE 454            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: END-USER FOOTPRINT             412

TABLE 455            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DETAILED LIST

OF KEY STARTUPS/SMES              415

TABLE 456            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: REGION FOOTPRINT (STARTUPS/SMES)           416

TABLE 457            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: SOLUTION/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–DECEMBER 2024 419

TABLE 458            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DEALS,

JANUARY 2021–DECEMBER 2024 420

TABLE 459            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: EXPANSIONS,

JANUARY 2021–DECEMBER 2024 421

TABLE 460            SAP SE: COMPANY OVERVIEW   423

TABLE 461            SAP SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED             424

TABLE 462            SAP SE: SOLUTION ENHANCEMENTS, JANUARY 2021–DECEMBER 2024     426

TABLE 463            ORACLE: COMPANY OVERVIEW                428

TABLE 464            ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED             429

TABLE 465            ORACLE: SOLUTION ENHANCEMENTS, JANUARY 2021–DECEMBER 2024 430

TABLE 466            ORACLE: DEALS, JANUARY 2021–DECEMBER 2024        431

TABLE 467            ORACLE: EXPANSIONS, JANUARY 2021–DECEMBER 2024                431

TABLE 468            IBM: COMPANY OVERVIEW         433

TABLE 469            IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED             434

TABLE 470            IBM: DEALS, JANUARY 2021–DECEMBER 2024                 435

TABLE 471            CARDINAL HEALTH: COMPANY OVERVIEW                 438

TABLE 472            CARDINAL HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED    439

TABLE 473            CARDINAL HEALTH: DEALS, JANUARY 2021–DECEMBER 2024                442

TABLE 474            CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–DECEMBER 2024     444

TABLE 475            INFOR (KOCH INDUSTRIES): COMPANY OVERVIEW          446

TABLE 476            INFOR (KOCH INDUSTRIES): PRODUCTS/SERVICES/SOLUTIONS OFFERED    446

TABLE 477            INFOR (KOCH INDUSTRIES): DEALS, JANUARY 2021–DECEMBER 2024     448

TABLE 478            MANHATTAN ASSOCIATES: COMPANY OVERVIEW          450

TABLE 479            MANHATTAN ASSOCIATES: PRODUCTS/SERVICES/SOLUTIONS OFFERED    451

TABLE 480            TECSYS INC.: COMPANY OVERVIEW        454

TABLE 481            TECSYS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    455

TABLE 482            TECSYS INC.: SOLUTION ENHANCEMENTS, JANUARY 2021–DECEMBER 2024 457

TABLE 483            TECSYS INC.: DEALS, JANUARY 2021–DECEMBER 2024        457

TABLE 484            GLOBAL HEALTHCARE EXCHANGE, LLC: COMPANY OVERVIEW   459

TABLE 485            GLOBAL HEALTHCARE EXCHANGE, LLC: PRODUCTS/SERVICES/

SOLUTIONS OFFERED   459

TABLE 486            GLOBAL HEALTHCARE EXCHANGE, LLC: SERVICE/SOLUTION LAUNCHES & ENHANCEMENTS, JANUARY 2021–DECEMBER 2024     462

TABLE 487          GLOBAL HEALTHCARE EXCHANGE, LLC: DEALS, JANUARY 2021–DECEMBER 2024 463

TABLE 488            GLOBAL HEALTHCARE EXCHANGE, LLC: EXPANSIONS, JANUARY 2021–

DECEMBER 2024                464

TABLE 489            EPICOR SOFTWARE CORPORATION: COMPANY OVERVIEW          465

TABLE 490            EPICOR SOFTWARE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    465

TABLE 491            EPICOR SOFTWARE CORPORATION: SOFTWARE LAUNCHES, JANUARY 2021–DECEMBER 2024        467

TABLE 492            EPICOR SOFTWARE CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 468

TABLE 493            CORCENTRIC, INC.: COMPANY OVERVIEW                 470

TABLE 494            CORCENTRIC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    470

TABLE 495            CORCENTRIC, INC.: DEALS, JANUARY 2021–DECEMBER 2024                471

TABLE 496            MCKESSON CORPORATION: COMPANY OVERVIEW          473

TABLE 497            MCKESSON CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    474

TABLE 498            MCKESSON CORPORATION: SOLUTION LAUNCHES, JANUARY 2021–

DECEMBER 2024                476

TABLE 499            MCKESSON CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024     476

TABLE 500            COUPA: COMPANY OVERVIEW  477

TABLE 501            COUPA: PRODUCTS/SERVICES/SOLUTIONS OFFERED             477

TABLE 502            COUPA: SOLUTION LAUNCHES, JANUARY 2021–DECEMBER 2024                479

TABLE 503            COUPA: DEALS, JANUARY 2021–DECEMBER 2024                 480

TABLE 504            COUPA: EXPANSIONS, JANUARY 2021–DECEMBER 2024                480

TABLE 505            BLUE YONDER GROUP, INC. (PANASONIC CORPORATION): COMPANY OVERVIEW                481

TABLE 506            BLUE YONDER GROUP, INC. (PANASONIC CORPORATION): PRODUCTS/SERVICES/SOLUTIONS OFFERED                 482

TABLE 507            BLUE YONDER GROUP, INC. (PANASONIC CORPORATION): PRODUCT ENHANCEMENTS, JANUARY 2021–DECEMBER 2024                484

TABLE 508            BLUE YONDER GROUP, INC. (PANASONIC CORPORATION): DEALS, JANUARY 2021–DECEMBER 2024                 485

TABLE 509            LOGITAG SYSTEMS: COMPANY OVERVIEW                 486

TABLE 510            LOGITAG SYSTEMS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    486

TABLE 511            PREMIER: COMPANY OVERVIEW               488

TABLE 512            PREMIER: PRODUCTS/SERVICES/SOLUTIONS OFFERED             489

TABLE 513            PREMIER: SOLUTION LAUNCHES, JANUARY 2021–DECEMBER 2024     490

TABLE 514            PREMIER: DEALS, JANUARY 2021–DECEMBER 2024        491

TABLE 515            WORKDAY, INC.: COMPANY OVERVIEW 494

TABLE 516            WORKDAY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    495

TABLE 517            WORKDAY, INC.: SOLUTION LAUNCHES, JANUARY 2021–DECEMBER 2024 496

TABLE 518            WORKDAY, INC.: DEALS, JANUARY 2021–DECEMBER 2024                497

TABLE 519            ARVATO SE (BERTELSMANN SE & CO. KGAA): COMPANY OVERVIEW   498

TABLE 520            ARVATO SE (BERTELSMANN SE & CO. KGAA): PRODUCTS/SERVICES/SOLUTIONS OFFERED    499

TABLE 521            ARVATO SE (BERTELSMANN SE & CO. KGAA): DEALS, JANUARY 2021–

DECEMBER 2024                501

TABLE 522            CENCORA, INC.: COMPANY OVERVIEW 502

TABLE 523            CENCORA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    503

TABLE 524            CENCORA, INC.: SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024     504

TABLE 525            CENCORA, INC.: DEALS, JANUARY 2021–DECEMBER 2024                504

TABLE 526            CENCORA, INC.: EXPANSIONS, JANUARY 2021–DECEMBER 2024                505

TABLE 527            GEP: COMPANY OVERVIEW         507

TABLE 528            GEP: PRODUCTS/SERVICES/SOLUTIONS OFFERED             508

TABLE 529            GEP: SOLUTION LAUNCHES, JANUARY 2021–DECEMBER 2024                510

TABLE 530            GEP: DEALS, JANUARY 2021–DECEMBER 2024                 510

TABLE 531            GEP: EXPANSIONS, JANUARY 2021–DECEMBER 2024        511

TABLE 532            JUMP TECHNOLOGIES, INC.: COMPANY OVERVIEW          512

TABLE 533            MEDSPHERE SYSTEMS CORPORATION: COMPANY OVERVIEW   513

TABLE 534            PROMEDEO: COMPANY OVERVIEW         514

TABLE 535            PROCUREMENT PARTNERS: COMPANY OVERVIEW          515

TABLE 536            VIZIENT INC.: COMPANY OVERVIEW      516

TABLE 537            INBEAM TECHNOLOGIES: COMPANY OVERVIEW          517

TABLE 538            CONNECTSX: COMPANY OVERVIEW       518

LIST OF FIGURES

FIGURE 1              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD                 43

FIGURE 2              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: YEARS CONSIDERED  45

FIGURE 3              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: RESEARCH DESIGN     49

FIGURE 4              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY DATA FROM SECONDARY SOURCES           51

FIGURE 5              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY PRIMARY SOURCES            52

FIGURE 6              HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY INDUSTRY INSIGHTS        53

FIGURE 7              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                53

FIGURE 8              MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            54

FIGURE 9              BOTTOM-UP APPROACH: END-USER SPENDING ON HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS                 55

FIGURE 10            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: CAGR PROJECTIONS

FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES          57

FIGURE 11            CAGR PROJECTION: SUPPLY-SIDE ANALYSIS                 58

FIGURE 12            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: TOP-DOWN APPROACH            58

FIGURE 13            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DATA TRIANGULATION            60

FIGURE 14            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING,

2024 VS. 2030 (USD MILLION)      63

FIGURE 15            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION,

2024 VS. 2030 (USD MILLION)      64

FIGURE 16            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024 VS. 2030 (USD MILLION)                 65

FIGURE 17            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024 VS. 2030 (USD MILLION)            65

FIGURE 18            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER,

2024 VS. 2030 (USD MILLION)      66

FIGURE 19            GEOGRAPHIC SNAPSHOT OF HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET               67

FIGURE 20            GROWING FOCUS ON CURBING SUPPLY CHAIN COSTS AND RISING DEMAND

FOR HEALTHCARE SERVICES TO PROPEL MARKET          68

FIGURE 21            MANUFACTURERS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET

SHARE IN 2023   69

FIGURE 22            CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       70

FIGURE 23            NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD       71

FIGURE 24            EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD          71

FIGURE 25            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    72

FIGURE 26            US: HEALTHCARE SECURITY BREACHES OF 500+ RECORDS, 2009–2023       78

FIGURE 27            US: INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023                78

FIGURE 28            REVENUE SHIFT IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET                82

FIGURE 29            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ECOSYSTEM ANALYSIS              86

FIGURE 30            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: VALUE CHAIN

ANALYSIS (2023)                88

FIGURE 31            INDICATIVE PRICING OF HEALTHCARE SUPPLY CHAIN MANAGEMENT

SOLUTIONS, BY KEY PLAYER      103

FIGURE 32            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE

FORCES ANALYSIS           105

FIGURE 33            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS  107

FIGURE 34            KEY BUYING CRITERIA FOR TOP THREE END USERS   108

FIGURE 35            PATENT PUBLICATION TRENDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2015–2024        109

FIGURE 36            JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT PATENTS (JANUARY 2015–DECEMBER 2024)         109

FIGURE 37            MAJOR PATENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET (JANUARY 2015–DECEMBER 2024)      110

FIGURE 38            RECENT FUNDING OF PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 117

FIGURE 39            MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING HEALTHCARE SUPPLY CHAIN MANAGEMENT ACROSS INDUSTRIES     120

FIGURE 40            NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT       216

FIGURE 41            ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT       304

FIGURE 42            REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2019–2023        402

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET (2023)                 403

FIGURE 44            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: RANKING OF KEY MARKET PLAYERS (2023)      406

FIGURE 45            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023                 407

FIGURE 46            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY FOOTPRINT             408

FIGURE 47            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        414

FIGURE 48            EV/EBITDA OF KEY VENDORS   416

FIGURE 49            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                417

FIGURE 50            HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 418

FIGURE 51            SAP SE: COMPANY SNAPSHOT   424

FIGURE 52            ORACLE: COMPANY SNAPSHOT                429

FIGURE 53            IBM: COMPANY SNAPSHOT         434

FIGURE 54            CARDINAL HEALTH: COMPANY SNAPSHOT                 439

FIGURE 55            MANHATTAN ASSOCIATES: COMPANY SNAPSHOT          451

FIGURE 56            TECSYS INC.: COMPANY SNAPSHOT        455

FIGURE 57            MCKESSON CORPORATION: COMPANY SNAPSHOT          474

FIGURE 58            BLUE YONDER GROUP, INC. (PANASONIC CORPORATION): COMPANY SNAPSHOT                482

FIGURE 59            PREMIER: COMPANY SNAPSHOT               488

FIGURE 60            WORKDAY, INC.: COMPANY SNAPSHOT 495

FIGURE 61            ARVATO SE (BERTELSMANN SE & CO. KGAA): COMPANY SNAPSHOT   499

FIGURE 62            CENCORA, INC.: COMPANY SNAPSHOT 502

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧